Based on the Assura Plc stock forecast from 2 analysts, the average analyst target price for Assura Plc is GBX 50.50 over the next 12 months. Assura Plc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Assura Plc is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Assura Plc’s stock price was GBX 41.80. Assura Plc’s stock price has changed by +4.34% over the past week, -0.48% over the past month and -15.76% over the last year.
No recent analyst target price found for Assura Plc
No recent average analyst rating found for Assura Plc
Company Overview Assura Plc
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040. Read Less
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assur...Read More
Frequently Asked Questions About Assura Plc (AGR:LSE) Stock
Based on ratings from 2 analysts Assura Plc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and hold ratings.
AGR:LSE stock's dividend yield is 7.83%.
Our analysis grades AGR:LSE stock's dividend yield at D-. This means that AGR:LSE stock's dividend yield is above 60% of the stocks in the REIT - Healthcare Facilities sector in the LSE exchange.
Based on this AGR:LSE may be a average dividend stock for its sector.
Based on targets from 2 analysts, the average taret price for AGR:LSE is GBX 50.50 over the next 12 months. The maximum analyst target price is GBX 53 while the minimum anlayst target price is GBX 48.
AGR:LSE stock's Price/Earning ratio is 12.02.
Our analysis grades AGR:LSE stock's Price / Earning ratio at F. This means that AGR:LSE stock's Price/Earning ratio is above 50% of the stocks in the REIT - Healthcare Facilities sector in the LSE exchange.
Based on this AGR:LSE may be fairly valued for its sector
The last closing price of AGR:LSE's stock was GBX 41.80.
The most recent market capitalization for AGR:LSE is GBX 1.26B.
Based on targets from 2 analysts, the average taret price for AGR:LSE is projected at GBX 50.50 over the next 12 months.
This means that AGR:LSE's stock price may go up by +20.81% over the next 12 months.
We can't find any ETFs which contains Assura Plc's stock.
As per our most recent records Assura Plc has 86 Employees.
Assura Plc's registered address is 3 Barrington Road, Altrincham, United Kingdom, WA14 1GY.
You can get more information about it from Assura Plc's website at https://www.assuraplc.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AGR:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
